MedTrace Logo

Brain Injury Therapy of Exercise and Enriched Environment

NCT03256643 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2020-03-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether exercise or exercise with enrichment is beneficial in individuals who previously had a head injury. The enrichment will consist of a cultural educational program that will include ethnic food, music, slides and a talk. A series of tests that measure mental function and balance will be done before and after the exercise or the exercise/enrichment program will be done to measure efficacy.

Conditions

  • Brain Injuries

Interventions

BEHAVIORAL

Exercise

Exercise intervention will consist of 8 exercise classes and exercises at home. A booklet will be given to each person that has a description and photograph of each exercise that designed to work on core strength and balance.

BEHAVIORAL

Delayed Exercise

People will be tested up to 40 weeks after beginning the intervention.

BEHAVIORAL

Exercise and enrichment

Exercise and enrichment will consist of the same exercise program described for the exercise intervention. The enrichment protocol consisting of cultural educational program will take place during the exercises and breaks for this group.

Sponsors & Collaborators

  • Wayne State University

    lead OTHER

Principal Investigators

  • Jean Peduzzi-Nelson, Ph.D. · Wayne State University I

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-01
Primary Completion
2018-07-01
Completion
2020-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03256643 on ClinicalTrials.gov